TrialPanorama/TrialPanorama-database huggingface dataset:
Study 30826071 — Predictive Biomarker (PRD): GABRB3 mRNA
Genes: GABRB3
Study 30826071 — Predictive Biomarker (PRD): GABRA5 mRNA
Genes: GABRA5
Study 30826071 — Predictive Biomarker (PRD): GABRG3 mRNA
Genes: GABRG3
Study 30826192 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 30826528 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 30827133 — Surrogate Endpoint (SUR): Blood pressure
Study 30827933 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30827933 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 30830886 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 30830886 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study 30832606 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30832732 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30833370 — Predictive Biomarker (PRD): RAPGEF5 mRNA
Genes: RAPGEF5; GFR; KIAA0277; MRGEF
Study 30834280 — Safety Biomarker (SAF): Hyaluronic acid
Study 30836948 — Surrogate Endpoint (SUR): Serum potassium
Study 30840064 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30840064 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 30840064 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 30840757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30840757 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30840787 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 30842026 — Surrogate Endpoint (SUR): Blood pressure
Study 30843160 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 30843184 — Safety Biomarker (SAF): Human leucocyte antigen
Study 30843659 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 30843659 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 30845934 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30845934 — Surrogate Endpoint (SUR): Blood pressure
Study 30846408 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30847861 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 30850381 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 30852546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30852966 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study 30853233 — Surrogate Endpoint (SUR): Blood pressure
Study 30853642 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 30855519 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 30855519 — Safety Biomarker (SAF): BDNF
Study 30857849 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30857956 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30858985 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 30858985 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30859424 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 30859504 — Surrogate Endpoint (SUR): Blood pressure
Study 30860496 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 30860496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30860945 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30863043 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 30863450 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 30865223 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 30865223 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30865223 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 30865223 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 30865367 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30865367 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30865549 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 30866657 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30866657 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30867154 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 30867337 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 30868550 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30870275 — Predictive Biomarker (PRD): NR1I2 mRNA
Genes: NR1I2; PXR
Study 30870275 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study 30870275 — Predictive Biomarker (PRD): PGR mRNA
Genes: PGR; NR3C3
Study 30870275 — Predictive Biomarker (PRD): CYP3A7 mRNA
Genes: CYP3A7
Study 30871484 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30872388 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30873942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30873942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30875094 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30876475 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 30876475 — Surrogate Endpoint (SUR): Serum triglycerides
Study 30876480 — Predictive Biomarker (PRD): SDC2 mRNA
Genes: SDC2; HSPG1
Study 30877753 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30878987 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 30879046 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30879249 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 30879979 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 30881452 — Surrogate Endpoint (SUR): Bone mineral density
Study 30883492 — Surrogate Endpoint (SUR): Bone mineral density
Study 30885203 — Safety Biomarker (SAF): Reactive oxygen species
Study 30887820 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 30888024 — Predictive Biomarker (PRD): KLRG1 mRNA
Genes: KLRG1; CLEC15A; MAFA; MAFAL
Study 30888024 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30888398 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 30890544 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 30890544 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 30891607 — Safety Biomarker (SAF): Interleukin 12
Study 30895238 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 30895244 — Surrogate Endpoint (SUR): Sperm parameters
Study 30895467 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study 30895467 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 30895467 — Predictive Biomarker (PRD): RORC mRNA
Genes: RORC; NR1F3; RORG; RZRG
Study 30896447 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 30896746 — Surrogate Endpoint (SUR): Bone mineral density
Study 30897531 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 30897531 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 30898607 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30901876 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 30901876 — Monitoring Biomarker (MOI): Cell-free DNA
Study 30902630 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 30902907 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30903140 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30903140 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 30903140 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 30903140 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 30903184 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 30903275 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study 30904228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30904742 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study 30904869 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 30904869 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 30904869 — Surrogate Endpoint (SUR): Pathological complete response
Study 30907744 — Surrogate Endpoint (SUR): Blood pressure
Study 30908927 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30912033 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30912033 — Surrogate Endpoint (SUR): Blood pressure
Study 30913032 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 30914909 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 30915029 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 30915112 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30915273 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 30915626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30916768 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 30917871 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30918029 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30918100 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30918950 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 30920244 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study 30920851 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30922315 — Predictive Biomarker (PRD): A1BG mRNA
Genes: A1BG
Study 30922315 — Predictive Biomarker (PRD): ITIH4 mRNA
Genes: ITIH4; IHRP; ITIHL1; PK120; PRO1851
Study 30922315 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 30922315 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 30922643 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 30922643 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 30922805 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30923464 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 30923464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30923749 — Surrogate Endpoint (SUR): Blood pressure
Study 30924406 — Predictive Biomarker (PRD): MEA1 mRNA
Genes: MEA1; MEA
Study 30924924 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study 30926081 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study 30926081 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 30927096 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30928393 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 30928393 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30928955 — Predictive Biomarker (PRD): OPN1SW mRNA
Genes: OPN1SW; BCP
Study 30929188 — Safety Biomarker (SAF): Hyaluronic acid
Study 30929556 — Surrogate Endpoint (SUR): Blood pressure
Study 30931746 — Surrogate Endpoint (SUR): Bone mineral density
Study 30932170 — Surrogate Endpoint (SUR): Blood pressure
Study 30933618 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 30935383 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 30935383 — Surrogate Endpoint (SUR): Serum testosterone
Study 30935391 — Predictive Biomarker (PRD): COL4A3 mRNA
Genes: COL4A3
Study 30935397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30935397 — Surrogate Endpoint (SUR): Blood pressure
Study 30935734 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30936057 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 30936057 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30937394 — Predictive Biomarker (PRD): MISP mRNA
Genes: MISP; C19orf21
Study 30937421 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 30937580 — Safety Biomarker (SAF): Interleukin 1
Study 30937580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30937899 — Predictive Biomarker (PRD): MC3R mRNA
Genes: MC3R
Study 30937899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30938688 — Surrogate Endpoint (SUR): Blood pressure
Study 30938714 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 30938714 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 30938714 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30939488 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study 30939489 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 30940149 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30942111 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 30943124 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 30943979 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30943979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30943998 — Surrogate Endpoint (SUR): Forced vital capacity
Study 30944020 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30944585 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 30945522 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30946162 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 30947753 — Predictive Biomarker (PRD): SH2D2A mRNA
Genes: SH2D2A; SCAP; TSAD; VRAP
Study 30948185 — Predictive Biomarker (PRD): SHD mRNA
Genes: SHD
Study 30952619 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 30952619 — Predictive Biomarker (PRD): KMT2D mRNA
Genes: KMT2D; ALR; MLL2; MLL4
Study 30952619 — Predictive Biomarker (PRD): KMT2C mRNA
Genes: KMT2C; HALR; KIAA1506; MLL3
Study 30952619 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 30952619 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 30952998 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study 30953148 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 30953148 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30953238 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30953533 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 30953560 — Monitoring Biomarker (MOI): Cell-free DNA
Study 30954166 — Predictive Biomarker (PRD): ORMDL3 mRNA
Genes: ORMDL3
Study 30954166 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 30954352 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30954510 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 30955188 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 30955357 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 30955983 — Surrogate Endpoint (SUR): Serum uric acid
Study 30961941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 30962222 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 30962222 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 30962681 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 30962703 — Surrogate Endpoint (SUR): Serum creatinine
Study 30963212 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30963212 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30963212 — Surrogate Endpoint (SUR): Pathological complete response
Study 30963691 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 30964439 — Surrogate Endpoint (SUR): Blood pressure
Study 30967392 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 30967392 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 30967435 — Surrogate Endpoint (SUR): Serum uric acid
Study 30967435 — Surrogate Endpoint (SUR): Serum creatinine
Study 30967435 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 30967435 — Surrogate Endpoint (SUR): Blood pressure
Study 30968114 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30968114 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30968255 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 30968255 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 30968255 — Predictive Biomarker (PRD): SDHA mRNA
Genes: SDHA; SDH2; SDHF
Study 30968255 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study 30968255 — Predictive Biomarker (PRD): ATG5 mRNA
Genes: ATG5; APG5L; ASP
Study 30969357 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 30969486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30969486 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 30972912 — Predictive Biomarker (PRD): FCER1A mRNA
Genes: FCER1A; FCE1A
Study 30973373 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 30975201 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 30976202 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study 30976202 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30976651 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 30976780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30976780 — Monitoring Biomarker (MOI): Alpha-1-acid glycoprotein 1
Genes: ORM1; AGP1
Study 30977792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30978179 — Surrogate Endpoint (SUR): Blood pressure
Study 30978502 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 30978502 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study 30978502 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30979546 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 30980071 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 30981000 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30981000 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study 30981000 — Predictive Biomarker (PRD): CRY1 mRNA
Genes: CRY1; PHLL1
Study 30981000 — Predictive Biomarker (PRD): PER1 mRNA
Genes: PER1; KIAA0482; PER; RIGUI
Study 30981000 — Predictive Biomarker (PRD): PER2 mRNA
Genes: PER2; KIAA0347
Study 30981008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30981783 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 30981987 — Monitoring Biomarker (MOI): Cell-free DNA
Study 30984354 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30984970 — Surrogate Endpoint (SUR): Blood pressure
Study 30985279 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 30986750 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30988080 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30988172 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 30989436 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2
Study 30989436 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 30991692 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 30991908 — Surrogate Endpoint (SUR): Blood pressure
Study 30991972 — Surrogate Endpoint (SUR): Blood pressure
Study 30994466 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 30995372 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30995373 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30997117 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 30997151 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30997633 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30998789 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30998789 — Monitoring Biomarker (MOI): HBV DNA
Study 31000755 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31003871 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 31003963 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study 31004409 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study 31005312 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 31005312 — Surrogate Endpoint (SUR): Blood pressure
Study 31005944 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4